[Structural analysis of cardiac beta myosin heavy chain gene in familial hypertrophic cardiomyopathy]. 1993

H Nishi, and H Harada, and A Kimura
Third Department of Medicine, Kurume University School of Medicine.

Hypertrophic cardiomyopathy (HCM) is a disease of unknown etiology characterized by cardiac hypertrophy and disarrays of myocardial fiber and fibrils. More than half of patients with HCM show an apparent family history consistent with autosomal dominant inheritance. Mutations in the cardiac beta myosin heavy chain (MHC) gene have recently been identified in several Caucasian HCM families and suspected to be causative. To date, 8 missense mutations had been reported in Caucasian HCM families. We have also analyzed the structure of cardiac beta MHC gene in Japanese patients with HCM, and found 3 missense mutations. The application of the techniques of molecular biology provides a new understanding of HCM, for example, preclinical diagnosis and prediction of prognosis.

UI MeSH Term Description Entries
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D002312 Cardiomyopathy, Hypertrophic A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). Cardiomyopathy, Hypertrophic Obstructive,Cardiomyopathies, Hypertrophic,Cardiomyopathies, Hypertrophic Obstructive,Hypertrophic Cardiomyopathies,Hypertrophic Cardiomyopathy,Hypertrophic Obstructive Cardiomyopathies,Hypertrophic Obstructive Cardiomyopathy,Obstructive Cardiomyopathies, Hypertrophic,Obstructive Cardiomyopathy, Hypertrophic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H Nishi, and H Harada, and A Kimura
February 2002, Circulation research,
H Nishi, and H Harada, and A Kimura
January 1994, The Journal of clinical investigation,
H Nishi, and H Harada, and A Kimura
August 2006, Revista espanola de cardiologia,
H Nishi, and H Harada, and A Kimura
August 2011, Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics,
H Nishi, and H Harada, and A Kimura
September 1995, American journal of medical genetics,
H Nishi, and H Harada, and A Kimura
April 1991, Molecular biology & medicine,
Copied contents to your clipboard!